{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T07:12:07Z","timestamp":1756192327648,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T00:00:00Z","timestamp":1537488000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key Program of Clinical Science","award":["WBYZ2011-873"],"award-info":[{"award-number":["WBYZ2011-873"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2016YFC0901500"],"award-info":[{"award-number":["2016YFC0901500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12902-018-0295-6","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T10:56:15Z","timestamp":1537527375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Chinese patient with 11\u03b2-hydroxylase deficiency due to novel compound heterozygous mutation in CYP11B1 gene: a case report"],"prefix":"10.1186","volume":"18","author":[{"given":"Xianxian","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaolin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,21]]},"reference":[{"issue":"Suppl 5","key":"295_CR1","first-page":"1315","volume":"13","author":"SF Witchel","year":"2000","unstructured":"Witchel SF, Aston CE. The role of heterozygosity for CYP21 in the polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2000;13(Suppl 5):1315\u20137.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"295_CR2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1056\/NEJMra021561","volume":"349","author":"PW Speiser","year":"2003","unstructured":"Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med. 2003;349(8):776\u201388. \n                    https:\/\/doi.org\/10.1056\/NEJMra021561\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"9477","key":"295_CR3","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(05)66736-0","volume":"365","author":"DP Merke","year":"2005","unstructured":"Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005;365(9477):2125\u201336. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(05)66736-0\n                    \n                  .","journal-title":"Lancet"},{"issue":"2","key":"295_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1210\/jcem-56-2-222","volume":"56","author":"M Zachmann","year":"1983","unstructured":"Zachmann M, Tassinari D, Prader A. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients. J Clin Endocrinol Metab. 1983;56(2):222\u20139. \n                    https:\/\/doi.org\/10.1210\/jcem-56-2-222\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"295_CR5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s12020-016-0957-y","volume":"53","author":"B Han","year":"2016","unstructured":"Han B, Xue L, Fan M, Zhao S, Liu W, Zhu H, et al. Clinical and molecular manifestation of fifteen 17OHD patients: a novel mutation and a founder effect. Endocrine. 2016;53(3):784\u201390. \n                    https:\/\/doi.org\/10.1007\/s12020-016-0957-y\n                    \n                  .","journal-title":"Endocrine"},{"issue":"4","key":"295_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1210\/edrv-15-4-421","volume":"15","author":"PC White","year":"1994","unstructured":"White PC, Curnow KM, Pascoe L. Disorders of steroid 11 beta-hydroxylase isozymes. Endocr Rev. 1994;15(4):421\u201338. \n                    https:\/\/doi.org\/10.1210\/edrv-15-4-421\n                    \n                  .","journal-title":"Endocr Rev"},{"issue":"3","key":"295_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1055\/s-2002-35389","volume":"20","author":"M Peter","year":"2002","unstructured":"Peter M. Congenital adrenal hyperplasia. 11beta-hydroxylase deficiency. Semin Reprod Med. 2002;20(3):249\u201354. \n                    https:\/\/doi.org\/10.1055\/s-2002-35389\n                    \n                  .","journal-title":"Semin Reprod Med"},{"issue":"1","key":"295_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0889-8529(08)70019-7","volume":"30","author":"PC White","year":"2001","unstructured":"White PC. Steroid 11 beta-hydroxylase deficiency and related disorders. Endocrinol Metab Clin N Am. 2001;30(1):61\u201379.","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"20","key":"295_CR9","doi-asserted-by":"publisher","first-page":"7193","DOI":"10.1073\/pnas.84.20.7193","volume":"84","author":"SC Chua","year":"1987","unstructured":"Chua SC, Szabo P, Vitek A, Grzeschik KH, John M, White PC. Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11). Proc Natl Acad Sci U S A. 1987;84(20):7193\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"295_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.steroids.2015.06.002","volume":"101","author":"L Xu","year":"2015","unstructured":"Xu L, Xia W, Wu X, Wang X, Zhao L, Nie M. Chimeric CYP11B2\/CYP11B1 causing 11beta-hydroxylase deficiency in Chinese patients with congenital adrenal hyperplasia. Steroids. 2015;101:51\u20135. \n                    https:\/\/doi.org\/10.1016\/j.steroids.2015.06.002\n                    \n                   Epub 2015 Jun 9.","journal-title":"Steroids"},{"issue":"11","key":"295_CR11","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1210\/jcem.85.11.6897","volume":"85","author":"O Chabre","year":"2000","unstructured":"Chabre O, Portrat-Doyen S, Chaffanjon P, Vivier J, Liakos P, Labat-Moleur F, Chambaz E, Morel Y, Defaye G. Bilateral laparoscopic adrenalectomy for congenital adrenal hyperplasia with severe hypertension, resulting from two novel mutations in splice donor sites of CYP11B1. J Clin Endocrinol Metab. 2000 Nov;85(11):4060\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"295_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0006-291X(05)81058-7","volume":"173","author":"T Kawainoto","year":"1990","unstructured":"Kawainoto T, Mitsuuchi Y, Ohnishi T, Ichikawa Y, Yokoyama Y, Sumimoto H, et al. Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. Biochem Biophys Res Commun. 1990;173(1):309\u201316.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"295_CR13","doi-asserted-by":"publisher","first-page":"E1933","DOI":"10.1073\/pnas.1621082114","volume":"114","author":"A Khattab","year":"2017","unstructured":"Khattab A, Haider S, Kumar A, Dhawan S, Alam D, Romero R, et al. Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. Proc Natl Acad Sci U S A. 2017;114(10):E1933\u201340. \n                    https:\/\/doi.org\/10.1073\/pnas.1621082114\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"295_CR14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1210\/jc.2009-0651","volume":"95","author":"S Parajes","year":"2010","unstructured":"Parajes S, Loidi L, Reisch N, Dhir V, Rose IT, Hampel R, et al. Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with nonclassic and three mutations causing classic 11{beta}-hydroxylase deficiency. J Clin Endocrinol Metab. 2010;95(2):779\u201388. \n                    https:\/\/doi.org\/10.1210\/jc.2009-0651\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"295_CR15","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1210\/jcem.81.8.8768848","volume":"81","author":"S Geley","year":"1996","unstructured":"Geley S, Kapelari K, Johrer K, Peter M, Glatzl J, Vierhapper H, et al. CYP11B1 mutations causing congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. J Clin Endocrinol Metab. 1996;81(8):2896\u2013901. \n                    https:\/\/doi.org\/10.1210\/jcem.81.8.8768848\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"295_CR16","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1073\/pnas.90.10.4552","volume":"90","author":"KM Curnow","year":"1993","unstructured":"Curnow KM, Slutsker L, Vitek J, Cole T, Speiser PW, New MI, et al. Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci U S A. 1993;90(10):4552\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"295_CR17","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1210\/jc.2006-0209","volume":"91","author":"N Krone","year":"2006","unstructured":"Krone N, Grischuk Y, Muller M, Volk RE, Grotzinger J, Holterhus PM, et al. Analyzing the functional and structural consequences of two point mutations (P94L and A368D) in the CYP11B1 gene causing congenital adrenal hyperplasia resulting from 11-hydroxylase deficiency. J Clin Endocrinol Metab. 2006;91(7):2682\u20138. \n                    https:\/\/doi.org\/10.1210\/jc.2006-0209\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"295_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ygcen.2011.12.017","volume":"175","author":"CI Ben","year":"2012","unstructured":"Ben CI, Riepe FG, Kahloul N, Kulle AE, Adala L, Mamai O, et al. Two novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11beta hydroxylase deficiency in a Tunisian family. Gen Comp Endocrinol. 2012;175(3):514\u20138. \n                    https:\/\/doi.org\/10.1016\/j.ygcen.2011.12.017\n                    \n                  .","journal-title":"Gen Comp Endocrinol"},{"issue":"4","key":"295_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000342871","volume":"78","author":"C Xu","year":"2012","unstructured":"Xu C, Qiao J, Liu W, Jiang X, Yan F, Wu J, et al. Identification and functional characterization of a large deletion of the CYP11B1 gene causing an 11beta-hydroxylase deficiency in a Chinese pedigree. Horm Res Paediatr. 2012;78(4):212\u20137. \n                    https:\/\/doi.org\/10.1159\/000342871\n                    \n                  .","journal-title":"Horm Res Paediatr"},{"key":"295_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jsbmb.2012.08.011","volume":"133","author":"M Zhang","year":"2013","unstructured":"Zhang M, Liu Y, Sun S, Zhang H, Wang W, Ning G, Li X. A prevalent and three novel mutations in CYP11B1 gene identified in Chinese patients with 11-beta hydroxylase deficiency. J Steroid Biochem Mol Biol. 2013;133:25\u20139. \n                    https:\/\/doi.org\/10.1016\/j.jsbmb.2012.08.011\n                    \n                  .","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9","key":"295_CR21","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1210\/jc.2008-2521","volume":"94","author":"FC Soardi","year":"2009","unstructured":"Soardi FC, Penachioni JY, Justo GZ, Bachega TA, Inacio M, Mendonca BB, et al. Novel mutations in CYP11B1 gene leading to 11 beta-hydroxylase deficiency in Brazilian patients. J Clin Endocrinol Metab. 2009;94(9):3481\u20135. \n                    https:\/\/doi.org\/10.1210\/jc.2008-2521\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"295_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0162-0134(01)00331-2","volume":"87","author":"NV Belkina","year":"2001","unstructured":"Belkina NV, Lisurek M, Ivanov AS, Bernhardt R. Modelling of three-dimensional structures of cytochromes P450 11B1 and 11B2. J Inorg Biochem. 2001;87(4):197\u2013207.","journal-title":"J Inorg Biochem"},{"issue":"7","key":"295_CR23","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1210\/jcem.86.7.7671","volume":"86","author":"S Portrat","year":"2001","unstructured":"Portrat S, Mulatero P, Curnow KM, Chaussain JL, Morel Y, Pascoe L. Deletion hybrid genes, due to unequal crossing over between CYP11B1 (11beta-hydroxylase) and CYP11B2(aldosterone synthase) cause steroid 11beta-hydroxylase deficiency and congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2001;86(7):3197\u2013201. \n                    https:\/\/doi.org\/10.1210\/jcem.86.7.7671\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"295_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12020-016-1189-x","volume":"55","author":"K Bulsari","year":"2017","unstructured":"Bulsari K, Falhammar H. Clinical perspectives in congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. Endocrine. 2017;55(1):19\u201336. \n                    https:\/\/doi.org\/10.1007\/s12020-016-1189-x\n                    \n                  .","journal-title":"Endocrine"},{"issue":"3","key":"295_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.tem.2008.01.002","volume":"19","author":"S Nimkarn","year":"2008","unstructured":"Nimkarn S, New MI. Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia. Trends Endocrinol Metab. 2008;19(3):96\u20139. \n                    https:\/\/doi.org\/10.1016\/j.tem.2008.01.002\n                    \n                  .","journal-title":"Trends Endocrinol Metab"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-018-0295-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12902-018-0295-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-018-0295-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T19:13:11Z","timestamp":1569006791000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-018-0295-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,21]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["295"],"URL":"https:\/\/doi.org\/10.1186\/s12902-018-0295-6","relation":{},"ISSN":["1472-6823"],"issn-type":[{"type":"electronic","value":"1472-6823"}],"subject":[],"published":{"date-parts":[[2018,9,21]]},"assertion":[{"value":"2 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and was approved by Peking Union Medical College Hospital\u2019s Research and Ethical Committee (JS1233).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient and his parents, including the permission for details and images related to the patient and his parents to be published. The patient and his parents were informed that the details and images would be freely available on the internet and may be seen by the general public. Copies of the consent forms are available for review by the editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"68"}}